US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 13.4900
  • -0.4700-3.37%
Close Aug 16 16:00 ET
  • 13.4900
  • 0.00000.00%
Post 20:02 ET
909.60MMarket Cap-8126P/E (TTM)

Perspective Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
Total revenue
0
0
0
-309.14%-5.24M
-34.40%1.91M
0
0
-64.67%3.55M
-7.56%2.51M
11.92%2.91M
Operating revenue
--0
--0
--0
-309.14%-5.24M
-34.40%1.91M
--0
--0
-64.67%3.55M
-7.56%2.51M
11.92%2.91M
Cost of revenue
-1.50%1.45M
-44.55%2.74M
15.76%1.58M
18.66%1.47M
Gross profit
-48.79%738K
-84.05%817K
-31.20%926K
5.80%1.44M
Operating expense
46.23%14.26M
33.54%13.01M
386.93%40.94M
145.78%7.45M
290.34%11M
9.75M
9.74M
-1.75%8.41M
24.31%3.03M
32.50%2.82M
Selling and administrative expenses
10.57%5.51M
-11.78%5.88M
196.38%21.06M
-24.24%1.69M
144.75%5.55M
--4.99M
--6.66M
-0.34%7.11M
13.44%2.24M
28.57%2.27M
-Selling and marketing expense
----
----
----
----
24.45%855K
----
----
-34.46%1.57M
-0.49%607K
18.24%687K
-General and administrative expense
10.57%5.51M
-11.78%5.88M
280.22%21.06M
162.25%4.27M
197.03%4.7M
--4.99M
--6.66M
16.88%5.54M
19.69%1.63M
33.64%1.58M
Research and development costs
72.72%9.28M
125.20%7.45M
1,538.05%21.31M
663.82%6.08M
942.08%5.72M
--5.37M
--3.31M
-8.83%1.3M
70.09%796K
51.66%549K
Other operating expenses
12.77%-526K
-39.48%-325K
---1.43M
---322K
---276K
---603K
---233K
----
----
----
Operating profit
-46.23%-14.26M
-33.54%-13.01M
-439.34%-40.94M
-323.79%-8.93M
-645.49%-10.26M
-9.75M
-9.74M
-120.86%-7.59M
-92.68%-2.11M
-80.10%-1.38M
Net non-operating interest income expense
1,039.18%3.05M
232.02%1.18M
51.52%850K
35.71%38K
555.17%190K
268K
356K
850.85%561K
-12.50%28K
38.10%29K
Non-operating interest income
946.26%3.08M
223.80%1.21M
66.49%934K
121.43%62K
603.45%204K
--294K
--374K
850.85%561K
-12.50%28K
38.10%29K
Non-operating interest expense
-11.54%23K
61.11%29K
--84K
--24K
--14K
--26K
--18K
----
----
----
Other net income (expense)
-4K
90.91%-2K
95.08%-15K
17K
-12K
-22K
-3,288.89%-305K
Earnings from equity interest
---4K
---2K
---17K
---5K
---12K
--0
--0
----
----
----
Special income (charges)
--0
--0
--0
--22K
--0
--0
---22K
-3,288.89%-305K
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
--0
--22K
--0
--0
---22K
-3,288.89%-305K
--0
--0
Other non- operating income (expenses)
----
----
--2K
--0
----
----
----
----
----
----
Income before tax
-18.22%-11.21M
-25.73%-11.83M
-446.78%-40.11M
-326.85%-8.87M
-648.33%-10.08M
-9.49M
-9.41M
-116.56%-7.34M
-95.85%-2.08M
-80.81%-1.35M
Income tax
0
0
-2.65M
7.85M
0
0
-10.5M
Net income
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,140.23%-25.77M
-648.33%-10.08M
-11.11M
-371K
-116.56%-7.34M
-95.85%-2.08M
-80.81%-1.35M
Net income continuous Operations
-18.22%-11.21M
-1,179.91%-11.83M
-410.63%-37.46M
-704.57%-16.72M
-648.33%-10.08M
---9.49M
--1.1M
-116.56%-7.34M
-95.85%-2.08M
-80.81%-1.35M
Net income discontinuous operations
73.52%-429K
68.55%-461K
---9.05M
----
----
---1.62M
---1.47M
----
----
----
Net income extraordinary
---61K
--2K
----
----
----
--0
--0
----
----
----
Minority interest income
Net income attributable to the parent company
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
-11.11M
-371K
-116.56%-7.34M
-95.85%-2.08M
-80.81%-1.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-5.38%-11.7M
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
-11.11M
-371K
-116.37%-7.34M
-95.85%-2.08M
-80.81%-1.35M
Basic earnings per share
55.00%-0.18
-0.2
-240.00%-1.7
-800.00%-0.9
-300.00%-0.4
-0.4
0
-66.67%-0.5
0.00%-0.1
0.00%-0.1
Diluted earnings per share
55.00%-0.18
-0.2
-240.00%-1.7
-800.00%-0.9
-300.00%-0.4
-0.4
0
-66.67%-0.5
0.00%-0.1
0.00%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022
Total revenue 000-309.14%-5.24M-34.40%1.91M00-64.67%3.55M-7.56%2.51M11.92%2.91M
Operating revenue --0--0--0-309.14%-5.24M-34.40%1.91M--0--0-64.67%3.55M-7.56%2.51M11.92%2.91M
Cost of revenue -1.50%1.45M-44.55%2.74M15.76%1.58M18.66%1.47M
Gross profit -48.79%738K-84.05%817K-31.20%926K5.80%1.44M
Operating expense 46.23%14.26M33.54%13.01M386.93%40.94M145.78%7.45M290.34%11M9.75M9.74M-1.75%8.41M24.31%3.03M32.50%2.82M
Selling and administrative expenses 10.57%5.51M-11.78%5.88M196.38%21.06M-24.24%1.69M144.75%5.55M--4.99M--6.66M-0.34%7.11M13.44%2.24M28.57%2.27M
-Selling and marketing expense ----------------24.45%855K---------34.46%1.57M-0.49%607K18.24%687K
-General and administrative expense 10.57%5.51M-11.78%5.88M280.22%21.06M162.25%4.27M197.03%4.7M--4.99M--6.66M16.88%5.54M19.69%1.63M33.64%1.58M
Research and development costs 72.72%9.28M125.20%7.45M1,538.05%21.31M663.82%6.08M942.08%5.72M--5.37M--3.31M-8.83%1.3M70.09%796K51.66%549K
Other operating expenses 12.77%-526K-39.48%-325K---1.43M---322K---276K---603K---233K------------
Operating profit -46.23%-14.26M-33.54%-13.01M-439.34%-40.94M-323.79%-8.93M-645.49%-10.26M-9.75M-9.74M-120.86%-7.59M-92.68%-2.11M-80.10%-1.38M
Net non-operating interest income expense 1,039.18%3.05M232.02%1.18M51.52%850K35.71%38K555.17%190K268K356K850.85%561K-12.50%28K38.10%29K
Non-operating interest income 946.26%3.08M223.80%1.21M66.49%934K121.43%62K603.45%204K--294K--374K850.85%561K-12.50%28K38.10%29K
Non-operating interest expense -11.54%23K61.11%29K--84K--24K--14K--26K--18K------------
Other net income (expense) -4K90.91%-2K95.08%-15K17K-12K-22K-3,288.89%-305K
Earnings from equity interest ---4K---2K---17K---5K---12K--0--0------------
Special income (charges) --0--0--0--22K--0--0---22K-3,288.89%-305K--0--0
-Gain on sale of property,plant,equipment --0--0--0--22K--0--0---22K-3,288.89%-305K--0--0
Other non- operating income (expenses) ----------2K--0------------------------
Income before tax -18.22%-11.21M-25.73%-11.83M-446.78%-40.11M-326.85%-8.87M-648.33%-10.08M-9.49M-9.41M-116.56%-7.34M-95.85%-2.08M-80.81%-1.35M
Income tax 00-2.65M7.85M00-10.5M
Net income -5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,140.23%-25.77M-648.33%-10.08M-11.11M-371K-116.56%-7.34M-95.85%-2.08M-80.81%-1.35M
Net income continuous Operations -18.22%-11.21M-1,179.91%-11.83M-410.63%-37.46M-704.57%-16.72M-648.33%-10.08M---9.49M--1.1M-116.56%-7.34M-95.85%-2.08M-80.81%-1.35M
Net income discontinuous operations 73.52%-429K68.55%-461K---9.05M-----------1.62M---1.47M------------
Net income extraordinary ---61K--2K--------------0--0------------
Minority interest income
Net income attributable to the parent company -5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M-11.11M-371K-116.56%-7.34M-95.85%-2.08M-80.81%-1.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -5.38%-11.7M-3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M-11.11M-371K-116.37%-7.34M-95.85%-2.08M-80.81%-1.35M
Basic earnings per share 55.00%-0.18-0.2-240.00%-1.7-800.00%-0.9-300.00%-0.4-0.40-66.67%-0.50.00%-0.10.00%-0.1
Diluted earnings per share 55.00%-0.18-0.2-240.00%-1.7-800.00%-0.9-300.00%-0.4-0.40-66.67%-0.50.00%-0.10.00%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg